Maintenance treatment with long-acting injectable antipsychotics comparing old with new

JAMA

Volumn 311, Issue 19, 2014, Pages 1973-1974

  Goff, Donald C ^a,b  

^a Nathan Kline Institute for Psychiatric Research   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; PALIPERIDONE; PROLACTIN; RISPERIDONE;

AKATHISIA; COMPARATIVE EFFECTIVENESS; DRUG ADMINISTRATION ROUTE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; GALACTORRHEA; GYNECOMASTIA; HUMAN; MAINTENANCE THERAPY; PARKINSONISM; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; TARDIVE DYSKINESIA; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; FEMALE; HALOPERIDOL; HUMANS; ISOXAZOLES; MALE; PALMITATES;

EID: 84900835455     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.4311     Document Type: Editorial

References (8)

1. Kishimoto T, Robenzadeh A, Leucht C, et al. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: ameta-analysis of randomized trials. Schizophr Bull. 2014;40(1):192-213.
2. Csernansky JG, Mahmoud R, Brenner R; Risperidone-USA-79 Study Group. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med. 2002;346(1):16-22. (Pubitemid 34438915)
3. Lieberman JA, Stroup TS, McEvoy JP, et al Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223. (Pubitemid 41345943)
4. Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Mol Psychiatry. 2013;18(1):53-66.
5. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962.
6. Rosenheck RA, Krystal JH, Lew R, et al. Long-acting risperidone and oral antipsychotics in unstable schizophrenia. N Engl J Med. 2011;364(13):1281.
7. McEvoy JP, Byerly M, Hamer RM, et al. Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.4310.
8. Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry. 2008;21(2):151-156. (Pubitemid 351339869)